Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

An ibuprofen arginine compound medicament for children

An arginine ibuprofen, children's technology, used in antipyretics, anti-inflammatory agents, drug delivery, etc.

Inactive Publication Date: 2006-12-13
韩志强
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] But at present, the range of use of arginine ibuprofen is mostly limited to adults and children over 12 years old, and the application in children under 12 years old, especially for the application in children under 3 years old to six months of age, has not been seen. Literature report

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] The arginine ibuprofen medicament suitable for children can be any one of oral preparations such as powder, tablet, capsule or liquid preparation.

[0023] When the dosage form is powder, it is calculated as ibuprofen, 0.1g per bag, suitable for children aged six months to 12 years old.

Embodiment 2

[0025] A kind of arginine ibuprofen medicament suitable for children as in Example 1, but the dosage form is any one of oral preparations such as tablet, capsule or liquid preparation.

Embodiment 3

[0027] A kind of arginine ibuprofen medicament suitable for children as embodiment 1 or 2 is effective in treating toothache in children from six months to 12 years of age, pain caused by trauma (for example, sports injury), joint and ligament pain , back pain, headache and fever caused by colds, acute upper respiratory infection, acute pharyngitis and other diseases.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an ibuprofen arginine medicament for children and its use in treating children's toothache, aches caused by trauma (such as sport injury), knuckle and ligament ache, back pain, headache, and fever caused by common cold, acute upper respiratory tract infection disease or acute laryngitis. The dosage types of the preparation include powder, tablets, capsules or liquid preparations.

Description

technical field [0001] The invention relates to an arginine ibuprofen medicament, in particular to an arginine ibuprofen medicament suitable for children. Background technique [0002] Ibuprofen is a phenylpropionic acid non-steroidal anti-inflammatory analgesic. Anti-inflammatory drugs work by inhibiting cyclooxygenase in the metabolism of arachidonic acid and reducing the synthesis of prostaglandins (PG). Their anti-inflammatory, analgesic and antipyretic effects are similar to those of aspirin and phenylbutazone. It is clinically used for fever caused by colds, acute upper respiratory infections, acute pharyngitis and other diseases; mild and moderate pain; rheumatoid arthritis and osteoarthritis and other rheumatic diseases have significant therapeutic effects. It is also clinically used for acute gout, headache, neuralgia, dysmenorrhea, soft tissue injury, etc. [0003] Ibuprofen is widely used clinically as an alkyl propionate pyretic analgesic and anti-inflammatory ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/08A61K9/14A61K9/20A61K9/48A61K31/192A61P29/00
Inventor 韩志强贾晓冬安德清曾杏雪田英
Owner 韩志强
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products